|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/02 | |
| A61K 47/06 | |||
| A61K 47/10 | |||
| A61K 47/12 | |||
| A61K 9/08 | |||
| A61M 11/00 | |||
| A61M 15/00 | |||
| A61K 31/46 | |||
| A61K 9/00 |
| (11) | Number of the document | 2897589 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14809570.6 |
| Date of filing the European patent application | 2014-11-21 | |
| (97) | Date of publication of the European application | 2015-07-29 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/066840 |
| Date | 2014-11-21 |
| (87) | Number | WO 2015/077574 |
| Date | 2015-05-28 |
| (30) | Number | Date | Country code |
| 201361907778 P | 2013-11-22 | US |
| (72) |
DALVI, Mukul, US
WU, Libo, US
|
| (73) |
Teva Branded Pharmaceutical Products R & D, Inc.,
41 Moores Road, Frazer, PA 19355,
US
|
| (54) | AN INHALABLE MEDICAMENT |
| AN INHALABLE MEDICAMENT |